| Literature DB >> 36187501 |
Xiaoyan Lei1, Dan Qin2, Gangming Zhu3.
Abstract
In order to assess the value of magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) in microscopic brain scans. Diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRI) changes over time in patients with traumatic brain injury (TBI) show a relationship between recovery from coma and overall Glasgow prognostic parameters. The value of DTI combined with MRI in evaluating TBI has been investigated. 10 patients with TBI received 10 evaluations of magnetic resonance imaging, DTI and MRI scans. Thalamic plate nucleus, reticular nucleus, and retinal developmental activity were measured in normal controls and TBI coma (2-3 weeks) and mild (>4 weeks) patients. Anisotropy, mean diffusion coefficient, axial diffusion coefficient, and radial diffusion coefficient were measured using MRI together with acetylaspartic acid, choline, creatinine, and lactic acid. Independent control t-tests were conducted between controls and TBI patients, and 1-test paired between moderate and severe injuries, and regression and correlation were evaluated. Evaluated for all measures and treatments. DTI and MRI scores in TBI patients differed from normal controls. DTI and MRI can predict the prognosis of TBI patients better. The limitations of the thalamus-retinal activation system are gradually restored. axial diffusion coefficient and radial diffusion coefficient can be used to evaluate the reliability of comatose patients with TBI. DTI and MRI scans of the patient's brain can predict recovery and guide treatment in TBI coma patients.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36187501 PMCID: PMC9519278 DOI: 10.1155/2022/8469939
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Composition of magnetic resonance imaging system.
Basic information of enrolled patients.
| Number | Gender | Age | Damage site | Convalescence | |
|---|---|---|---|---|---|
| CRS-R | mGOS | ||||
| 1 | Male | 49 | Frontal lobe | 24 | 6 |
| 2 | Male | 36 | Frontal lobe | 24 | 6 |
| 3 | Male | 67 | Frontal lobe, temporal lobe, and parietal lobe | 9 | 3 |
| 4 | Male | 28 | Frontal and parietal lobes | 14 | 4 |
| 5 | Female | 55 | Occipital lobe and cerebellum | 15 | 4 |
| 6 | Female | 47 | Parietal and frontal lobes | 11 | 3 |
| 7 | Female | 48 | Thalamus and frontal lobe | 10 | 3 |
| 8 | Female | 34 | Parietal and frontal lobes | 21 | 5 |
| 9 | Male | 30 | Insula thalamus | 8 | 3 |
| 10 | Female | 51 | Frontal and parietal lobes | 19 | 5 |
Paired t-test of acute and mild DTI parameters.
| Region of interest | FA | MD | Da | Dr |
|---|---|---|---|---|
| Board core | 0.04∗ | 0.03∗ | 0.04∗ | 0.04∗ |
| Reticular nucleus | 0.02∗ | 0.04∗ | 0.04∗ | 0.01∗ |
| Pontine | 0.03∗ | 0.02∗ | 0.12 | 0.04∗ |
| Medulla oblongata | 0.03∗ | 0.04∗ | 0.23 | 0.01∗ |
Independent sample t-test of acute and light DTI parameters of TBI patients and normal control group.
| Region of interest | Acute phase vs Normal control group | Light vs Normal control group | ||||||
|---|---|---|---|---|---|---|---|---|
| FA | MD | Da | Dr | FA | MD | Da | Dr | |
| Board core | 0.04 | 0.03 | <0.01 | <0.01 | 0.09 | 0.04 | 0.13 | 0.30 |
| Reticular nucleus | <0.01 | 0.03 | <0.01 | 0.03 | 0.11 | 0.03 | 0.21 | 0.14 |
| Pontine | 0.03 | <0.01 | <0.01 | <0.01 | 0.02 | 0.02 | <0.01 | 0.01 |
| Medulla oblongata | <0.01 | <0.01 | <0.01 | <0.01 | 0.03 | 0.03 | <0.01 | 0.02 |
Figure 2Comparison results of independent sample t-test between light DTI parameters of TBI patients and normal control group.
Correlation analysis between FA parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| FA | Board core | 0.16 | 0.03 | 0.37 | 0.02 | 0.80 | 0.01 | 0.36 | 0.02 |
| Reticular nucleus | 0.20 | 0.06 | 0.34 | 0.02 | 0.11 | 0.20 | 0.22 | 0.01 | |
| Pons | 0.20 | 0.14 | 0.46 | 0.01 | 0.12 | 0.29 | 0.31 | 0.01 | |
| Medulla oblongata | 0.10 | 0.10 | 0.27 | 0.03 | 0.26 | 0.09 | 0.20 | 0.03 | |
Correlation analysis between MD parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| MD | Board core | 0.039 | 0.07 | 0.48 | 0.01 | 0.1 | 0.09 | 0.35 | 0.019 |
| Reticular nucleus | 0.10 | 0.10 | 0.30 | 0.039 | 0.21 | 0.16 | 0.47 | 0.029 | |
| Pons | 0.34 | 0.019 | 0.24 | 0.029 | 0.66 | 0.019 | 0.66 | 0.01 | |
| Medulla oblongata | 0.48 | 0.019 | 0.43 | 0.029 | 0.77 | 0.019 | 0.48 | 0.01 | |
Correlation analysis between Da parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| Da | Board core | 0.44 | 0.04 | 0.32 | 0.01 | 0.44 | 0.019 | 0.29 | 0.03 |
| Reticular nucleus | 0.54 | 0.01 | 0.38 | 0.01 | 0.53 | 0.029 | 0.47 | 0.03 | |
| Pons | 0.41 | 0.01 | 0.56 | 0.02 | 0.19 | 0.26 | 0.45 | 0.02 | |
| Medulla oblongata | 0.26 | 0.02 | 0.38 | 0.02 | 0.51 | 0.01 | 0.38 | 0.02 | |
Correlation analysis between Dr parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| Dr | Board core | 0.48 | 0.01 | 0.46 | 0.02 | 0.42 | 0.01 | 0.40 | 0.03 |
| Reticular nucleus | 0.38 | 0.02 | 0.28 | 0.03 | 0.33 | 0.01 | 0.48 | 0.02 | |
| Pons | 0.46 | 0.01 | 0.37 | 0.01 | 0.54 | 0.01 | 0.20 | 0.02 | |
| Medulla oblongata | 0.40 | 0.01 | 0.40 | 0.01 | 0.45 | 0.01 | 0.45 | 0.01 | |
Paired t-test of acute and light MRI parameters.
| Region of interest | NAACT | NAA/CHO | CHO/Cr |
|---|---|---|---|
| Board core | 0.19∗ | 0.02∗ | 0.03∗ |
| Reticular nucleus | 0.39∗ | 0.01∗ | 0.05∗ |
| Pontine | 0.05 | 0.08 | 0.04∗ |
| Medulla oblongata | 0.11 | 0.39∗ | 0.02∗ |
Independent sample t-test of acute phase and light MRI parameters of TBI patients and normal control group.
| Region of interest | Acute phase vs Normal control group | Light vs Normal control group | ||||
|---|---|---|---|---|---|---|
| NAN/Cr | NAA/CHO | CHO/Cr | NAN/Cr | NAA/CHO | CHO/Cr | |
| Board core | 0.04∗ | 0.03∗ | 0.03∗ | 0.02∗ | 0.10 | 0.07 |
| Reticular nucleus | 0.01∗ | 0.03∗ | 0.02∗ | 0.04∗ | 0.08 | 0.10 |
| Pontine | 0.02∗ | 0.02∗ | 0.01∗ | 0.08 | 0.02∗ | 0.01∗ |
| Medulla oblongata | 0.02∗ | 0.02∗ | 0.02∗ | 0.09 | 0.02∗ | 0.03∗ |
Figure 3Comparison results of independent sample t-test between acute phase and light MRI parameters of TBI patients and normal control group.
Correlation analysis between NAACR parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| NAN/Cr | Board core | 0.35 | 0.03 | 0.14 | 0.03 | 0.15 | 0.03 | 0.35 | 0.02 |
| Reticular nucleus | 0.47 | 0.02 | 0.20 | 0.02 | 0.21 | 0.01 | 0.24 | 0.03 | |
| Pons | 0.3 | 0.02 | 0.25 | 0.02 | 0.14 | 0.02 | 0.12 | 0.03 | |
| Medulla oblongata | 0.2 | 0.02 | 0.22 | 0.02 | 0.16 | 0.02 | 0.22 | 0.01 | |
Correlation analysis between NAA/CHO parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| NAA/CHO | Board core | 0.05 | 0.20 | 0.20 | 0.01 | 0.07 | 0.05 | 0.22 | 0.04 |
| Reticular nucleus | 0.07 | 0.10 | 0.17 | 0.01 | 0.10 | 0.07 | 0.23 | 0.05 | |
| Pons | 0.26 | 0.03 | 0.24 | 0.02 | 0.20 | 0.03 | 0.37 | 0.01 | |
| Medulla oblongata | 0.28 | 0.03 | 0.21 | 0.02 | 0.29 | 0.03 | 0.29 | 0.02 | |
Correlation analysis between CHO/Cr parameters and CRS-R and mGOS in recovery period.
| Parameter | Region of interest | Correlation analysis with CRS-R | Correlation analysis with mGOS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute stage | Light | Acute stage | Light | ||||||
|
|
|
|
|
|
|
|
| ||
| CHO/Cr | Board core | 0.10 | 0.09 | 0.10 | 0.08 | 0.12 | 0.05 | 0.20 | 0.08 |
| Reticular nucleus | 0.19 | 0.06 | 0.23 | 0.07 | 0.08 | 0.08 | 0.10 | 0.13 | |
| Pons | 0.38 | 0.07 | 0.30 | 0.29 | 0.16 | 0.07 | 0.43 | 0.02 | |
| Medulla oblongata | 0.07 | 0.12 | 0.47 | 0.19 | 0.09 | 0.08 | 0.38 | 0.03 | |